NEW YORK (Genomeweb) — A study comprehensively analyzing the genomes of more than 1,500 neuroblastoma cases has better determined the prognostic significance of ALK mutations and other alterations in neuroblastoma, and has biochemically investigated many of these variants to determine which ones

NEW YORK (GenomeWeb) – Qiagen today said that it has signed a master collaboration agreement to develop and commercialize companion diagnostics for existing Novartis products as well as compounds in Novartis' development pipeline.

Originally published Nov. 10.
NEW YORK (GenomeWeb) – Consulting firm Diaceutics has released a report that shows pharmaceutical companies' readiness to develop and deliver personalized medicines has improved since 2010, at least according to the numbers.

NEW YORK (GenomeWeb) – During its fiscal third quarter, Thermo Fisher Scientific took $12.8 million in charges related to severance, the company disclosed in its Form 10-Q filed recently with the US Securities and Exchange Commission.

Enterome Bioscience is collaborating with AbbVie to create molecular diagnostic tools to monitor the gut microbiome in patients with Crohn's disease and other microbiome-related diseases.

Originally published Nov. 10.

NEW YORK (GenomeWeb) – Quest Diagnostics last week launched BRCAvantage Plus, a testing service for gauging breast cancer risk through which patients can learn whether they harbor mutations in BRCA and other genes.

Vanderbilt University has appointed Nancy Cox the founding director of the new Vanderbilt Genetics Institute, effective Jan. 1, 2015. She also will be a professor of genetics and direct the division of genetic medicine in the department of medicine.

NEW YORK (GenomeWeb) – Genomics England today announced the launch of the Clinical Interpretation Partnership (GeCIP) to bring together UK researchers and the National Health Service to translate findings from the 100,000 Genomes Project for use in the early diagnosis of diseases.

NEW YORK (GenomeWeb) – Vela Diagnostics said today that it has completed the listing of its next-generation sequencing system with the US Food and Drug Administration as a class II medical device.

Pages

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.